Jones, S. A. Et Al. 2017. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.. Orphanet journal of rare diseases , vol.12, no.1 , 25.

Jones, S. A., Rojas-Caro, S., Quinn, A. G., Friedman, M., Marulkar, S., Ezgu, F. S., ... Zaki, O.(2017). Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.. Orphanet journal of rare diseases , vol.12, no.1, 25.

Jones, Simon Et Al. "Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.," Orphanet journal of rare diseases , vol.12, no.1, 25, 2017

Jones, Simon A. Et Al. "Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.." Orphanet journal of rare diseases , vol.12, no.1, pp.25, 2017

Jones, S. A. Et Al. (2017) . "Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.." Orphanet journal of rare diseases , vol.12, no.1, p.25.

@article{article, author={Simon A. Jones Et Al. }, title={Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.}, journal={Orphanet journal of rare diseases}, year=2017, pages={25} }